InsidersTradesSigma
TLX: directors' dealings · Australia · ASX
ASX:tlxAU·ASXMcap 3.8Bn€Healthcare & Pharma
Explore the full insider trade history of TLX, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Healthcare & Pharma sector, TLX has logged 5 public disclosures. Market capitalisation: €3.8bn. The latest transaction was disclosed on 13 May 2026 — Other. Among the most active insiders: Unknown. The full history is accessible without an account.
5
Insider Decl.
0
Thresholds
€607,977
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
14.72 €
Analyst consensus
11 analystsStrong buy
18.00 €Target 23.34 €(+59%)32.00 €
Income statement
Revenue803.8 M€
Gross profit426.4 M€53% margin
Net income−7.1 M€-0.9% margin
Valuation
PER (forward)116.3x
P/Book8.3x
Beta0.65
Balance sheet & cash
Market cap3.79 Bn€
Total debt467.1 M€
Free Cash Flow−61.1 M€
Debt / Equity112%
Profitability & ownership
ROE-1.9%
ROA1.1%
% insiders17.3%
% institutions21.9%
Last declaration on 13 May 2026
Declarations5 total
Executives●Purchase26ASX
€607,97767,935 shares@ €8.94940.016% mcap100.0% of flow
ShareASX
ASX:2924-03084212-3A692242·
Ideal exit: 24 Jan 2027 (T+270)
Executives●Change in Substantial Holding7ASX
ShareASX
ASX:2924-03083454-3A692125·
5 of 5 declarations
